USPTO 2015–2025 USPTO PatentsView US Corporation

Verily Life Sciences LLC

USPTO PatentsView assignee record — 926 granted patents across 141 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

926
Total patents granted
141
CPC technology areas
18.8
Avg claims per patent
+59%
5-year filing velocity

Portfolio overview

Verily Life Sciences LLC has been granted 926 US utility patents between 2016 and 2025, placing Verily Life Sciences LLC at rank #478 across all assignees tracked by PlainPatent. This portfolio spans 141 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Verily Life Sciences LLC is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 64.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 568 grants, compared with 358 in the 2015–2019 window — a +59% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Verily Life Sciences LLC's 18.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Verily Life Sciences LLC against peers pursuing similar technology classes.

How does Verily compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Verily holds 926 patents — placing it at rank #478 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2016–2025

050100150 2016201720182019202020212022202320242025 70
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Verily Life Sciences LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 36 3.9%
2017 85 9.2%
2018 110 11.9%
2019 127 13.7%
2020 131 14.1%
2021 109 11.8%
2022 89 9.6%
2023 87 9.4%
2024 82 8.9%
2025 70 7.6%

Which technologies does Verily Life Sciences LLC patent most?

Top 15 of 141 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Diversified
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#478

Across all tracked assignees

Innovation Score

64.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Verily Life Sciences LLC hold?
Verily Life Sciences LLC holds 926 US granted patents filed between 2016 and 2025, spanning 141 technology areas.
What is Verily Life Sciences LLC's Innovation Score?
Verily Life Sciences LLC has an Innovation Score of 64.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Verily Life Sciences LLC focus on?
Verily Life Sciences LLC's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 474 patents. The company has filed patents in 141 CPC subclasses total.
Is Verily Life Sciences LLC's patent filing rate increasing or decreasing?
Verily Life Sciences LLC's recent filing velocity is +59% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Verily Life Sciences LLC's patents?
Verily Life Sciences LLC's patents average 18.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Verily Life Sciences LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope